Boston, MA, August 28, 2016 --(PR.com
)-- Transplantation refers to a surgical procedure involving replacement of a failed or damaged organ, tissue or cell in the human body with a new one. In order to check the donor and recipient compatibility and to monitor the post transplantation rejections the transplantation procedure requires diagnostic tests. Transplantation Diagnostics market is advancing at a rapid pace, as estimated by IQ4I Research the Transplantation Diagnostics global market is expected to grow at a high double-digit CAGR to from 2015-2022.
Increased incidences of life style diseases like cancer, diabetes, heart diseases etc. associated with unhealthy habits are likely to damage the organs or tissues, requiring the necessity of transplantation procedures, which is simultaneously expected to propel the growth of transplantation diagnostics market. Along with this the rising disposable incomes in the developing countries, rapid growth in aging and diseased population are some of the drivers of market. However some issues like high test cost, limited reimbursement facility and some ethical issues may hinder the growth of transplantation diagnostics market.
The Transplantation Diagnostics global market by technology is segmented into Molecular methods and Non-molecular methods. Molecular methods are further divided into PCR based molecular method and Sequencing based molecular method. PCR based methods are further sub-segmented into SSO-PCR, SSP-PCR and others. Others include SNP-PCR and RFLP-PCR. Sequencing based molecular method is further sub-segmented into NGS and Sanger Sequencing. Non-molecular methods are of three types namely Serological tests, Mixed Lymphocyte Culture assay and Flow Cytometry. The Non-molecular methods occupied highest market in Transplantation Diagnostics technology market.
The Transplantation Diagnostics global market by products is segmented into Instruments, Consumables and Software & Services. The Consumables segment is estimated to grow at strong CAGR from 2015 to 2022.
The Transplantation Diagnostics global market by screening methods is segmented into Pre-transplantation screening and Post-transplantation screening. The Post-transplantation screening segment is estimated to grow at strong CAGR from 2015 to 2022. The Transplantation Diagnostics global market by Application is segmented into Diagnostic (Medical) and Research application. Diagnostic (Medical) application is further segmented into Solid Organ Transplantation, Tissue transplantation and Stem-cell transplantation. Solid organ transplantation is further sub-segmented into Kidney, Liver, Heart and Others. The Diagnostic (Medical) application occupied highest market in Transplantation Diagnostics application market. The End-users consists of Hospitals and transplant centers, Diagnostic Laboratories and Research Laboratories & Academic Institutions. The Hospitals and transplant centers contributed the largest revenue as per estimates of IQ4I Research.
The Transplantation Diagnostics global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue market in 2015 due to increasing number of organ and tissue transplantation, higher healthcare expenditure, high adoption rate of advanced technology, reducing cost of sequencing HLA genes are factors propelling market growth in this region.
There is a huge growth potential for transplantation diagnostics with added opportunities from new avenues like cell-free DNA which is likely to propel the market with very high growth rate.
Some of the prominent players in transplantation diagnostics market include Abbott Laboratories, Inc. (U.S), Bio-Rad Laboratories, Inc. (U.S), CareDx, Inc. (U.S), Illumina, Inc. (U.S), Immucor, Inc.(U.S), Linkage biosciences (U.S), Qiagen N.V. (Netherlands), Roche (Switzerland), Thermo Fisher Scientific, Inc. (U.S).